Share This Page
Details for Patent: D342994
✉ Email this page to a colleague
Summary for Patent: D342994
| Title: | Inhalator |
| Abstract: | |
| Inventor(s): | Paul K. Rand, David J. Hearne |
| Assignee: | Glaxo Group Ltd |
| Application Number: | US07/821,555 |
|
Patent Claim Types: see list of patent claims | |
| Patent landscape, scope, and claims: | United States Design Patent D342,994: Scope, Claim Structure, and LandscapeWhat is US Design Patent D342,994 and what does it cover?US Design Patent D342,994 is a design patent that protects the ornamental design of a product as shown in the issued patent drawings. Design patents in the USPTO system do not claim functional aspects; they claim the visual appearance. Because the design claim scope in a USPTO design patent is tied to the figures (drawings), the controlling “scope” is the set of visual views and the specific surface/shape features depicted. For a drug portfolio context: a US design patent may relate to the appearance of a drug-related article (for example, a container, packaging, device housing, or an identifiable branded visual form). However, the enforceable scope of D342,994 remains limited to the ornamentation shown in its drawings, not the drug composition, method of treatment, or manufacturing. What are the claim(s) in D342,994?USPTO utility and design patents use different claim frameworks. For design patents, the claim is typically singular and covers the ornamental design shown. Design patent claim structure (standard form):
This structure means infringement analysis centers on substantial similarity between the accused design and the patented design as a whole. What is the scope test used to assess infringement for a design patent?Design patent infringement uses a point-of-view standard anchored in:
The legal consequence for portfolio strategy: competitors can often design around by altering features that change the overall visual impression, even if the overall article type remains the same. What is the effective field of protection for D342,994?For a US design patent, protection is limited to:
Protection is not extended to:
Claim landscape summary (what matters for freedom-to-operate and enforcement)Because the claim is visual, the relevant landscape questions are:
For investment diligence, this drives two diligence tracks:
How broad is the claim coverage in practice?What features usually define the protected “overall visual impression”?Even where the patent claim is broad in wording, design patents narrow in practice to the drawings. The features that typically carry most weight in overall impression include:
The stronger a competitor’s resemblance on these elements, the higher the infringement risk. What would be “easy” versus “hard” design-arounds?Easy design-arounds generally involve:
Hard design-arounds generally involve:
What is the claim’s relationship to utility patent coverage?Design patents often complement utility patents by covering branded appearance. Utility patents cover:
Design patents can still matter commercially even when there is no utility overlap, because brand protection and product layout can be a differentiator. Patent landscape: where to find relevant overlapsWhat comparable patent classes tend to overlap with design patents in drug-related markets?Design patents that sit adjacent to drug commercialization typically fall into these practical categories:
Overlap risk depends on whether later entities claim ornamental designs of the same article with similar compositional layout. What types of prior art constrain novelty or obviousness of design patents?Design patents are examined for:
In litigation, the main relevance also includes:
Timeline and term considerationsHow long does a US design patent last?For US design patents filed and issued under the modern term rules, design patent term is typically:
For any enforceability window analysis, term start is tied to the grant date, not priority date, and requires confirmation against the actual issue date of D342,994. Enforcement posture: what D342,994 is likely used forHow do design patents in drug-adjacent markets get enforced?Design patents are often asserted to:
What damages and remedies are typical?Remedies may include:
A design patent’s narrow visual scope means damages attach to infringing versions that are visually close enough to drive overall impression similarity. Actionable landscape workstreams for investors and licensing teamsWorkstream 1: Build a “visual impression” family mapCreate a matrix with:
Workstream 2: Identify design-around-safe feature swapsUse the D342,994 drawings to tag:
Then test market candidates:
Key Takeaways
FAQs1) Does US design patent D342,994 protect the drug’s active ingredient?No. A design patent protects only the ornamental appearance of the article shown in the drawings. 2) How many claims does a typical design patent like D342,994 have?Design patents typically have a single claim covering the ornamental design “as shown and described” in the patent drawings. 3) What controls infringement for design patents?The overall visual impression of the patented design compared to the accused design. 4) Can competitors avoid infringement without changing the product function?Yes. Competitors can often reduce infringement risk by changing the visual features that drive overall impression, even if the product’s function stays the same. 5) Why does the patent drawings set matter so much?Because the claim scope in a design patent is tied to the depicted ornamental design in those figures; the drawings define what is protected. References[1] United States Patent and Trademark Office (USPTO). Design patent claim standards and infringement principles (design patents claim ornamental design as shown in drawings). USPTO Patent Center / relevant design patent examination materials. More… ↓ |
Drugs Protected by US Patent D342994
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
Foreign Priority and PCT Information for Patent: D342994
International Family Members for US Patent D342994
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Australia | 116827 | ⤷ Start Trial | |||
| Australia | 116878 | ⤷ Start Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
